fda compounding semaglutide enforcement october 2025 glp-1 news issued 25 warning letters to telehealth companies for false FDA Warns on Certain Forms

This broader endocrine interaction reflects its ghrelin-mimetic nature

Patients should be aware of important warning signs requiring medical attention: persistent severe abdominal pain with or without vomiting (possible pancreatitis), right upper quadrant pain/fever/jaundice (possible gallbladder disease), reduced urination or dizziness (possible dehydration/kidney issues), visual changes (especially in diabetes patients), or allergic reactions

Shamban, who has served as a clinical investigator on many FDA trials, notes that when a product is approved by the agency, it first requires a fairly expensive trial process

Get Your Personal Quest Detox Timeline Enter your weight, body type, and use frequency